Not yet recruiting
Acute lymphocytic leukaemia+6
Not yet recruitingA Study Testing the Safety of CD19-Targeted CAR T-Cell Therapy in Children and Young Adults with Relapsed or Refractory B-Cell Cancers
InvestigationalNo placebo
A Study Testing the Safety of CD19-Targeted CAR T-Cell Therapy in Children and Young Adults with Relapsed or Refractory B-Cell Cancers
InvestigationalNo placebo
- Disease:Acute lymphocytic leukaemiaAcute lymphocytic leukaemia recurrent+5
- Substances:MB-HUCART19.1
Countries:
The Netherlands
The Netherlands- Participants:0–17 years · 18–64 years
- Substances:MB-HUCART19.1
- Sponsor:Prinses Maxima Centrum voor Kinderoncologie B.V.
